In about 0.1% of cases people have had anaphylactic reactions to<unk>  and in about 0.2% of cases the drug has caused pancreatitis. Use with insulin or sulfonylurea may cause hypoglycemia. In some cases, people with no kidney disease have had acute kidney injury and in some people with existing kidney disease the condition has gotten worse. Because<unk>  is a peptide people can and do develop an immune response to it that will eventually make the drug ineffective; people who have developed antibodies to<unk>  tend to have more inflammation at the injection site. At least 5% of people had nausea, vomiting, diarrhea, headache, or dizziness after taking<unk> .
Lixisenatide
Linaclotide
Pramlintide
Tirzepatide
Glibenclamide
Canagliflozin
Linagliptin
Eluxadoline